A New Cholesterol-Lowering Drug at What Price?
By Kate Greenwood [Cross-posted at Health Reform Watch] This summer, the Food and Drug Administration (FDA) is expected to approve the first entries in a new class of drugs that lower patients’ low-density lipoprotein (LDL) cholesterol…